Correlation Between Leap Therapeutics and Phio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Leap Therapeutics and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leap Therapeutics and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Leap Therapeutics and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on Leap Therapeutics and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leap Therapeutics with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leap Therapeutics and Phio Pharmaceuticals.
Diversification Opportunities for Leap Therapeutics and Phio Pharmaceuticals
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Leap and Phio is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and Leap Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leap Therapeutics are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of Leap Therapeutics i.e., Leap Therapeutics and Phio Pharmaceuticals go up and down completely randomly.
Pair Corralation between Leap Therapeutics and Phio Pharmaceuticals
Given the investment horizon of 90 days Leap Therapeutics is expected to under-perform the Phio Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Leap Therapeutics is 3.67 times less risky than Phio Pharmaceuticals. The stock trades about -0.2 of its potential returns per unit of risk. The Phio Pharmaceuticals Corp is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 193.00 in Phio Pharmaceuticals Corp on December 27, 2024 and sell it today you would lose (62.00) from holding Phio Pharmaceuticals Corp or give up 32.12% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Leap Therapeutics vs. Phio Pharmaceuticals Corp
Performance |
Timeline |
Leap Therapeutics |
Phio Pharmaceuticals Corp |
Leap Therapeutics and Phio Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Leap Therapeutics and Phio Pharmaceuticals
The main advantage of trading using opposite Leap Therapeutics and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leap Therapeutics position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.Leap Therapeutics vs. X4 Pharmaceuticals | Leap Therapeutics vs. Terns Pharmaceuticals | Leap Therapeutics vs. Day One Biopharmaceuticals | Leap Therapeutics vs. PDS Biotechnology Corp |
Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |